Benitec Biopharma Inc.

BNTC Nasdaq SEC CIK 1808898
Follow Benitec Biopharma Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2026 USD · US GAAP
Net income −$12.9M
EPS, diluted -
Operating cash flow −$4.9M
Operating income −$14.4M

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$60M−$40M−$20M$0$20MFY18FY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26-−$45.7M
FY25-−$37.9M
FY24$0−$21.8M
FY23$75K−$19.6M
FY22$73K−$18.2M
FY21$59K−$13.9M
FY20$102K−$8.3M
FY19$12.2M$2.6M
FY18--
MarginsShare of revenue
  • Operating margin
  • Net margin
−30000%−20000%−10000%0%10000%FY18FY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearOperating marginNet margin
FY26--
FY25--
FY24--
FY23−25441.3%−26082.7%
FY22−24457.5%−24942.5%
FY21−23044.1%−23528.8%
FY20−8118.6%−8111.8%
FY1921.2%21.4%
FY18--
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0$10MFY18FY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$16.6M
FY25−$23.6M
FY24−$19.6M
FY23−$18M
FY22−$15.9M
FY21−$13.1M
FY20−$7.6M
FY19$4.4M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Benitec Biopharma
  • Healthcare median
−30000%−20000%−10000%0%10000%FY18FY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearBenitec BiopharmaHealthcare median
FY26-−11.1%
FY25-−30.6%
FY24-−47%
FY23−26082.7%−58%
FY22−24942.5%−80.4%
FY21−23528.8%−71.8%
FY20−8111.8%−62.2%
FY1921.4%−46.2%
FY18-−49.6%